IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Soleno Therapeutics Inc

CUSIP: 834203119 | 7 institutional holders

Quarters

Q4 2017Q3 2017Q2 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2017

Bollard Group LLC2,197
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Bollard Group LLC
2,197$00.0%CoreVery LowBoston, MA2018-01-29